Search results
Results from the WOW.Com Content Network
Learn how medications can be used to treat substance use disorders, sustain recovery and prevent overdose. The use of medications, in combination with counseling and behavioral therapies, to provide a “whole-patient” approach to the treatment of substance use disorders.
SAMHSA offers a variety of training resources on the treatment of substance use disorder treatment topics to educate and assist programs and practitioners to provide evidence-based treatment.
SAMHSA’S DEFINITION OF MAT. Medication-assisted treatment is the use of FDA-approved medications, in combination with counseling and behavioral therapies, to provide a “whole-patient” approach to the treatment of substance use disorders. More information about MAT from SAMHSA is available at.
This manual provides clinical practice guidelines for using medications in the medication-assisted treatment of alcohol use disorder. It offers guidance on prescribing acamprosate, disulfiram, oral naltrexone, and extended-release injectable naltrexone. The manual also discusses patient management.
Medication-assisted treatment (MAT) is an evidence-based treatment for opioid use disorder that uses FDA-approved pharmacotherapy in combination with counseling and behavioral therapies to treat substance use disorders.
each year due to the use of alcohol (Centers for Disease Control and Prevention, 2013), and drug overdose is the leading cause of accidental death in the United States, with more than 72,000 lethal drug overdoses estimated in 2017 and 63,632 in 2016 (National Institute on Drug Abuse, 2018).
On the following pages you can fill out and submit to SAMHSA an on-line form SMA-162, and supporting documents, for Provisional (initial) Certification of a new Opioid Treatment Program (OTP). Note: Only SMA-162s for provisional certification of a new OTP can be submitted at this site.
DSM-5 integrates the two DSM-IV disorders, alcohol abuse and alcohol dependence, into a single disorder called alcohol use disorder (AUD) with mild, moderate, and severe subclassifications. Under DSM-5, anyone meeting any two of the 11 criteria during the same 12-month period would receive a diagnosis of AUD.
Programs seeking provisional certification as an OTP must use the online Form SMA-162: Application for Certification to Use Opioid Drugs in a Treatment Program. The OTP completes and electronically submits the SMA-162 to SAMHSA.
I. PROGRAM DESCRIPTION. 1. PURPOSE. The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT), is accepting applications for fiscal year (FY) 2021 Medication-Assisted Treatment - Prescription Drug and Opioid Addiction (Short Title: MAT-PDOA) grants.